N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141094 |
| CAS No | 1233340-43-6 |
| Mol.F. | C4H4N2O |
| Mol.Wt. | 96.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141095 |
| CAS No | NA |
| Mol.F. | C11H8N2O2 |
| Mol.Wt. | 200.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141096 |
| CAS No | NA |
| Mol.F. | C21H22N2O8 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141097 |
| CAS No | NA |
| Mol.F. | C5H12N2O4 |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141098 |
| CAS No | NA |
| Mol.F. | C4H10N2O5 |
| Mol.Wt. | 166.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141099 |
| CAS No | NA |
| Mol.F. | C31H32N6O5 |
| Mol.Wt. | 568.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141100 |
| CAS No | NA |
| Mol.F. | C24H19N5O5 |
| Mol.Wt. | 457.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141101 |
| CAS No | NA |
| Mol.F. | C13H19N5O2 |
| Mol.Wt. | 277.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141102 |
| CAS No | NA |
| Mol.F. | C33H34N6O6 |
| Mol.Wt. | 610.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141103 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O5 |
| Mol.Wt. | 356.8 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141104 |
| CAS No | NA |
| Mol.F. | C14H19ClN4O3 |
| Mol.Wt. | 326.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141105 |
| CAS No | NA |
| Mol.F. | C22H23ClN6O3 |
| Mol.Wt. | 454.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141106 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O4 |
| Mol.Wt. | 483.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141107 |
| CAS No | NA |
| Mol.F. | C14H20N4O3 |
| Mol.Wt. | 292.34 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141108 |
| CAS No | NA |
| Mol.F. | C12H13ClN4O2 |
| Mol.Wt. | 280.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141109 |
| CAS No | NA |
| Mol.F. | C22H23ClN6O3 |
| Mol.Wt. | 454.9 |
| INV STATUS | CUSTOM SYNTHESIS |